Company Profile

Halo Labs (AKA: Optofluidics Inc)
Profile last edited on: 9/9/22      CAGE: 62FQ0      UEI:

Business Identifier: High throughput aggregate, visible and subvisible particle analysis for biopharmaceutical formulation, stability, and product quality control
Year Founded
2010
First Award
2010
Latest Award
2018
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3711 Market Street Suite 970
Philadelphia, PA 19104
   (215) 253-5777
   info@opfluid.com
   www.opfluid.com
Location: Single
Congr. District: 03
County: Philadelphia

Public Profile

Previously dba as Optofluidics, Inc. - now renamed Halo Labs - is a scientific instrumentation company commercializing poprietary nanotechnological devices to perform leading edge particle analysis and nanomanipulation applications for the life science and materials industries: high throughput biopharmaceutical quality control tools. The firm develops microfluidic and biophotonic devices for single molecule analytics, point of care medical diagnostics, and biosensing and nanomedicine. Products include Molecular NanoTweezer, a protein discovery tool that handles the smallest forms of matter; and Molecular Medic that detects changes in blood-borne biomarkers to diagnose late phase hemorrhagic shock and traumatic brain injury. The company's products have applications in Particle Identification, Stability & Coating Analysis, and Optical Tweezing.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2018 1 NIH $203,830
Project Title: Partelligence
2017 2 NIH $1,649,652
Project Title: Excelsior: a High Throughput Particle Spectroscopic Characterization System for Biologic Qa/Qc
2017 2 NSF $1,450,614
Project Title: Single Molecule NanoTweezers
2017 2 DOC $399,980
Project Title: Protein Qspec: an Improved Method for Rapid Characterization of Protein Aggregates in Biologic Drugs for Increased Quality and Safety
2015 2 NIH $1,085,735
Project Title: Bioprism: an Optical Nanoparticle Sorting Assay

Key People / Management

  David Erickson -- Co-Founder & Chief Executive Officer

  Rick Gordon -- Chief Executive Officer

  Bernardo Cordovez -- Co-Founder & Chief Executive Officer

  Chris Earhart

  Robert W Hart -- Co-Founder, President & Chief Technical Officer